Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Rasmus Steen Pedersen"'
Autor:
Kim Brøsen, Tore Bjerregaard Stage, Søren Feddersen, Per Damkier, Rasmus Steen Pedersen, Kurt Højlund, John Teilmann Larsen, Mette Marie Hougaard Christensen
Publikováno v:
British Journal of Clinical Pharmacology. 79:298-306
Aims Our objective was to investigate the steady-state pharmacokinetic and pharmacodynamic interaction between the antidepressive herbal medicine St John's wort and the antidiabetic drug metformin.
Autor:
Horst Beier, Alain Rochette, Nicholas H. G. Holford, Frank Stüber, Ulrike M. Stamer, Sam Holford, Iñaki F. Trocóniz, Karel Allegaert, Rasmus Steen Pedersen, Brian J. Anderson, Jan de Hoon
Publikováno v:
Allegaert, K, Holford, N, Anderson, B J, Holford, S, Stuber, F, Rochette, A, Trocóniz, I F, Beier, H, de Hoon, J N, Pedersen, R S & Stamer, U 2015, ' Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans : a pooled pharmacokinetic study ', Clinical Pharmacokinetics, vol. 54, no. 2, pp. 167-178 . https://doi.org/10.1007/s40262-014-0191-9
BACKGROUND AND OBJECTIVES: We aimed to study the impact of size, maturation and cytochrome P450 2D6 (CYP2D6) genotype activity score as predictors of intravenous tramadol disposition.METHODS: Tramadol and O-desmethyl tramadol (M1) observations in 295
Autor:
Rasmus Steen Pedersen, Thomas P. Enggaard, Lene Noehr-Jensen, Soeren Mikkelsen, Flemming Nielsen, Soeren H. Sindrup, Stine Thorhauge Zwisler, Kim Brøsen
Publikováno v:
Zwisler, S T, Enggaard, T P, Noehr-Jensen, L, Pedersen, R S, Mikkelsen, S, Nielsen, F, Brøsen, K, Sindrup, S H & Brøsen, K 2009, ' The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism ', Basic & Clinical Pharmacology & Toxicology, vol. 104, no. 4, pp. 335-344 . https://doi.org/10.1111/j.1742-7843.2009.00378.x
Udgivelsesdato: 2009-Apr Oxycodone is O-demethylated by CYP2D6 to oxymorphone which is a potent micro-receptor agonist. The CYP2D6 oxidation polymorphism divides the Caucasian population in two phenotypes: approximately 8% with no enzyme activity, po
Autor:
Rasmus Steen Pedersen, Mette Marie Hougaard Christensen, Kim Brøsen, Lene Christiansen, Kaare Christensen, Tore Bjerregaard Stage, Per Damkier
Publikováno v:
Stage, T B, Damkier, P, Pedersen, R S, Christensen, M M H, Christiansen, L, Christensen, K & Brosen, K 2015, ' A twin study of the trough plasma steady-state concentration of metformin ', Pharmacogenetics and Genomics, vol. 25, no. 5, pp. 259-262 . https://doi.org/10.1097/FPC.0000000000000133
OBJECTIVE: The aim of this study was to determine the intrapair similarity in trough steady-state plasma concentrations of metformin in monozygotic and dizygotic twin pairs.METHODS: We included 16 twin pairs (eight monozygotic and eight dizygotic twi
Publikováno v:
University of Southern Denmark
Pedersen, R S, Damkier, P & Brøsen, K 2006, ' Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers ', European Journal of Clinical Pharmacology, vol. 62, pp. 513-521 .
Pedersen, R S, Damkier, P & Brøsen, K 2006, ' Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers ', European Journal of Clinical Pharmacology, vol. 62, pp. 513-521 .
To describe in detail the intravenous, single oral and multiple oral dose enantioselective pharmacokinetics of tramadol in CYP2D6 extensive metabolizers (EMs) and poor metabolizers (PMs).Eight EMs and eight PMs conducted three phases as an open-label
Publikováno v:
Clinical Pharmacology & Therapeutics. 77:312-323
Objective Tramadol hydrochloride (INN, tramadol) exerts its antinociceptive action through a monoaminergic effect mediated by the parent compound and an opioid effect mediated mainly by the O-demethylated metabolite (+)-M1. O-demethylation is catalyz
Autor:
Tore Bjerregaard Stage, Rasmus Steen Pedersen, Pernille Just Vinholt, Alaa Bilal el Achwah, Per Damkier, Flemming Nielsen, Kim Brøsen
Publikováno v:
Pedersen, R S, Nielsen, F, Stage, T B, Vinholt, P J, Achwah, A B E, Damkier, P & Brøsen, K 2014, ' CYP2C19*17 increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel ', Clinical and Experimental Pharmacology and Physiology, vol. 41, no. 11, pp. 870-878 . https://doi.org/10.1111/1440-1681.12297
The aim of the present study was to determine the impact of CYP2C19*17 on the pharmacokinetics and pharmacodynamics of the active metabolite of clopidogrel and the pharmacokinetics of proguanil. Thus, we conducted an open-label two-phase cross-over s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee568f7916d137fa31b1b4c9ae953bd
https://portal.findresearcher.sdu.dk/da/publications/613b1db8-da98-4fdd-9f06-ba0e39c7514d
https://portal.findresearcher.sdu.dk/da/publications/613b1db8-da98-4fdd-9f06-ba0e39c7514d
Autor:
Tore Bjerregaard Stage, Lene Christiansen, Mette Marie Hougaard Christensen, Rasmus Steen Pedersen, Kim Brøsen, Per Damkier, Kaare Christensen
Publikováno v:
Clinical Therapeutics. 37:e116-e117
ObjectiveThe aim of this study was to determine the intrapair similarity in trough steady-state plasma concentrations of metformin in monozygotic and dizygotic twin pairs.MethodsWe included 16 twin pairs (eight monozygotic and eight dizygotic twin pa
Autor:
Kim Brøsen, Flemming Nielsen, Henning Beck-Nielsen, Mette Marie Hougaard Christensen, Rasmus Steen Pedersen, Charlotte Brasch-Andersen, Tore Bjerregaard Stage, Per Damkier
Publikováno v:
Hougaard Christensen, M M, Pedersen, R S, Stage, T B, Brasch-Andersen, C, Nielsen, F, Damkier, P, Beck-Nielsen, H & Brøsen, K 2013, ' A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin ', Pharmacogenetics and Genomics, vol. 23, no. 10, pp. 526-534 . https://doi.org/10.1097/FPC.0b013e328364a57d
OBJECTIVE: The aim of this study was to determine the association between the renal clearance (CLrenal) of metformin in healthy Caucasian volunteers and the single-nucleotide polymorphism (SNP) c.808G>T (rs316019) in OCT2 as well as the relevance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05eb6280be25dc95b2b380eac171bf4
https://portal.findresearcher.sdu.dk/da/publications/9fea3319-3344-49d1-9f57-69ed6cdf3e41
https://portal.findresearcher.sdu.dk/da/publications/9fea3319-3344-49d1-9f57-69ed6cdf3e41
Publikováno v:
Pedersen, R S, Nøhr-Jensen, L & Brøsen, K 2013, ' Inhibitory effect of oral contraceptives on CYP2C19 activity is not significant in carriers of the CYP2C19*17 allele ', Clinical and Experimental Pharmacology & Physiology (Online), vol. 40, no. 10, pp. 683-688 . https://doi.org/10.1111/1440-1681.12153
The purpose of the present study was to examine whether cytochrome P450 2C19 (CYP2C19) in carriers of the CYP2C19*17 allele is inhibited in vivo by oral contraceptives (OC). Retrospective CYP2C19 phenotyping according to omeprazole : 5-OH-omeprazole